Nivalis Therapeutics, Inc. (NVLS) insider have most recently took part in a trading activity. On Jun 20, 2017 Biotechnology Value Fund L P, 10% Owner bought 17,806 shares having total worth of $40,064 at the price of $2.25 per share, following the transaction a total of 201,811 shares owned by Biotechnology Value Fund L P. Before this latest buy, Biotechnology Value Fund L P purchased NVLS at 4 other times during the past twelve months, for a total investment of $707,390 at an average of $2.3 per share.
The stock has experienced a total of 9 insider trades in the past three months. These trades include 9 buy trades. Furthermore, over the past 12 months , the stock was traded 13 times by insiders. In 3 of these trades, the insider was a seller while an employee of the company was the buyer in 10 instances.
|Time Frame||Number of Insider Buy||Number of Insider Sell||Stock Price Change(%)|
Nivalis Therapeutics, Inc. (NVLS) last announced its earnings results on May 1, 2017. The company reported -0.57 earnings per share (EPS) for the quarter. During the same quarter in the previous year, the company posted -0.51 earnings per share.
|earnings per share||-0.57||-0.50||-0.55||-0.42||-0.39||-1.41|
Latest posts by William White (see all)
- Insider Trading Review: FS Investment Corporation $FSIC - January 13, 2018
- Insider Trader Watch: ENERTOPIA CORP $ENRT - January 13, 2018
- Insider Trading in Focus: Swiss Helvetia Fund, Inc. (The) $SWZ - January 13, 2018